StonvexLoading…
StonvexCore line items from GDS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | ¥11.43B | ¥10.32B | ¥9.78B | ¥9.27B |
Operating Income | ¥-55.75M | ¥1.15B | ¥-2.21B | ¥713.23M |
Net Income | ¥949.64M | ¥3.43B | ¥-4.29B | ¥-1.27B |
EPS (Diluted) | ¥0.55 | ¥2.27 | ¥-2.96 | ¥-1.03 |
Total Assets | ¥80.00B | ¥73.65B | ¥74.45B | ¥74.81B |
Total Liabilities | ¥52.26B | ¥49.98B | ¥54.32B | ¥50.63B |
Cash & Equivalents | ¥14.31B | ¥7.87B | ¥7.50B | ¥8.21B |
Free Cash Flow OCF − CapEx | ¥-1.33B | ¥-1.23B | ¥-1.13B | ¥-3.06B |
Shares Outstanding | 1.64B | 1.48B | 1.47B | 1.46B |